Related references
Note: Only part of the references are listed.Cost-Effectiveness and Quality-Adjusted Survival of Watch and Wait After Complete Response to Chemoradiotherapy for Rectal Cancer
Jacob A. Miller et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Impact of the Coronavirus (COVID-19) pandemic on surgical practice - Part 1
Ahmed Al-Jabir et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
Yiyi Zhang et al.
BMC CANCER (2020)
STROCSS 2019 Guideline: Strengthening the reporting of cohort studies in surgery
Riaz Agha et al.
INTERNATIONAL JOURNAL OF SURGERY (2019)
Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling
S. Goncalves-Ribeiro et al.
ANNALS OF ONCOLOGY (2017)
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
R. Glynne-Jones et al.
ANNALS OF ONCOLOGY (2017)
Distance to the Anal Verge Is Associated With Pathologic Complete Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
Sunil V. Patel et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis
Xiao-Jie Wang et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2016)
Predictors of pathologic complete response after preoperative concurrent chemoradiotherapy of rectal cancer: a single center experience
Euncheol Choi et al.
RADIATION ONCOLOGY JOURNAL (2016)
Nonoperative Management of Rectal Cancer: Identifying the Ideal Patients
Angelita Habr-Gama et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2015)
Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer
Jan Pander et al.
PLOS ONE (2015)
Clinical Criteria Underestimate Complete Pathological Response in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
Fraser M. Smith et al.
DISEASES OF THE COLON & RECTUM (2014)
Current Controversies in Neoadjuvant Chemoradiation of Rectal Cancer
P. Terry Phang et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Interval to surgery after neoadjuvant treatment for colorectal cancer
Nir Wasserberg
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Preoperative Long Course Chemoirradiation in a Developing Country for Rectal Carcinoma: Kuala Lumpur Hospital Experience
Wei Ching Lee et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer: Are We Getting Closer to Anal Cancer Management?
Angelita Habr-Gama et al.
DISEASES OF THE COLON & RECTUM (2013)
Complete Response after Neoadjuvant Therapy in Rectal Cancer: To Operate or Not to Operate?
Georgia Dedemadi et al.
DIGESTIVE DISEASES (2012)
Nonoperative Approaches to Rectal Cancer: A Critical Evaluation
Angelita Habr-Gama et al.
SEMINARS IN RADIATION ONCOLOGY (2011)
Complete Clinical Response After Neoadjuvant Chemoradiation Therapy for Distal Rectal Cancer: Characterization of Clinical and Endoscopic Findings for Standardization
Angelita Habr-Gama et al.
DISEASES OF THE COLON & RECTUM (2010)
Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy
Angelita Habr-Gama et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2006)
Preoperative versus postoperative chemoradiotherapy for rectal cancer
R Sauer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
